Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma Revenue

In the year 2025, Lyell Immunopharma had annual revenue of $36.00K, down -40.98%. Lyell Immunopharma had revenue of $6.00K in the quarter ending December 31, 2025, a decrease of -45.45%.

• Revenue (ttm): $36.00K
• Revenue Growth: -40.98%
• P/S Ratio: 14,042.55
• Revenue / Employee: $120
• Employees: 300
• Market Cap: 502.74M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	36.00K	-25.00K	-40.98%
Dec 31, 2024	61.00K	-69.00K	-53.08%
Dec 31, 2023	130.00K	-84.55M	-99.85%
Dec 31, 2022	84.68M	74.03M	695.15%
Dec 31, 2021	10.65M	2.89M	37.31%
Dec 31, 2020	7.76M	7.10M	1,080.52%
Dec 31, 2019	657.00K	-	-